I'm sure this has been addressed before on the list, but I could not pull
anything up from the archives.

This question is mainly for those of you who are classified as 501(c)3
organizations and are doing research for pharmaceutical companies.  What is
your organization's view regarding the unrelated business income tax in
relation to the income derived from drug studies?  I have my own thoughts,
but am curious as to how others interpret the IRS rules and regulations.

Thanks for your comments.

Jennifer

Jennifer Sharp
Contract Attorney
Arkansas Children's Hospital Research Institute
1120 Marshall Street
Little Rock, AR  72202
501-320-3571
501-320-2705 (Fax)

======================================================================
 Instructions on how to use the RESADM-L Mailing List, including
 subscription information and a web-searchable archive, are available
 via our web site at http://www.hrinet.org (click on "Listserv Lists")
======================================================================